BCLC STAGE C HEPATOCELLULAR CARCINOMA
Clinical trials for BCLC STAGE C HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BCLC STAGE C HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for BCLC STAGE C HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive microspheres offer new hope for inoperable liver cancer
Disease control OngoingThis study is testing a treatment called selective internal radiation therapy (SIRT) for people with liver cancer that cannot be removed by surgery. Tiny radioactive beads are injected into the liver to deliver radiation directly to tumors. The goal is to shrink the cancer and co…
Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA
Phase: NA • Sponsor: Sirtex Medical • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Immunotherapy duo after radiation shows promise for inoperable liver cancer
Disease control OngoingThis early-phase study tests whether giving two immunotherapy drugs (durvalumab and tremelimumab) after a targeted radiation procedure can help people with advanced liver cancer that cannot be surgically removed. The trial includes 25 adults whose cancer has spread within the liv…
Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 07, 2026 18:43 UTC